SEC Form 4 · accession 0001144204-16-093311

DERMA SCIENCES, INC. · DSCI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Jan 29, 2015

Accepted (ET)

Apr 7, 2016 · 6:10 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000892160

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F2	Jan 29, 2015	X	100,000	$6.25	A	998,630	I	By Comvita Limited
Common Stock^F2	Jan 29, 2015	X	133,333	$5.50	A	1,131,963	I	By Comvita Limited

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series N Warrants^F4,F2	$6.25	Jan 29, 2015	X	100,000	D	Feb 23, 2010	Feb 22, 2015	Common Stock	100,000	0	I
Series Q Warrants^F4,F2	$5.50	Jan 29, 2015	X	133,333	D	Feb 23, 2010	Feb 22, 2015	Common Stock	133,333	0	I

F1The acquisition of the securities reported herein resulted from the exercise by Comvita Limited of derivative securities (Series N and Series Q Warrants) exempt under Exchange Act Rule 16b-6(b).
F2The securities reported herein are held by Comvita Limited. Brett Hewlett is the former Chief Executive Officer and a current Advisor to the Board of Directors of Comvita Limited and therefore may be deemed to share voting and investment power with respect to these securities held by Comvita Limited. Mr. Hewlett disclaims beneficial ownership of these securities held by Comvita Limited.
F3The disposition of the securities reported herein resulted from the exercise by Comvita Limited of in-the-money derivative securities (Series N and Series Q Warrants) exempt under Rule 16b-6(b).
F4The securities reported herein were originally issued to Comvita Limited on February 23, 2010.